Ascendis Pharma AS (A71) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.05x

Ascendis Pharma AS (A71) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €3.39 Million (capex €3.39 Million ) from operating cash flow of €73.40 Million. See Ascendis Pharma AS (A71) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

€3.39 Million
Capex + Investments

Operating Cash Flow

€73.40 Million
EUR

Capital Expenditures

€3.39 Million
EUR

Ascendis Pharma AS Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for Ascendis Pharma AS across 1 annual periods. For the full cash flow conversion analysis, see Ascendis Pharma AS cash flow conversion.

Annual Cash Flow Reinvestment Rate for Ascendis Pharma AS (2025–2025)

Year-by-year capital reinvestment analysis for Ascendis Pharma AS. See financial agility of Ascendis Pharma AS to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.16x €8.48 Million €53.90 Million €8.48 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow